Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages

Cell Communication and Signaling

Volumn 16, Issue 1, 2018, Pages

  Popěna, Ineta ^a   Abols, Arturs ^b   Saulite, Liga ^a   Pleiko, Karlis ^a   Zandberga, Elina ^b   Jěkabsons, Kaspars ^a   Endzeliņš, Edgars ^b   Llorente, Alicia ^c   Lině, Aija ^b   Riekstiņa, Una ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

^b LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

colorectal cancer; cytokines; endocytosis; Extracellular vesicles; macrophages; monocytes

Indexed keywords

CELL SURFACE RECEPTOR; CHEMOKINE; CYTOKINE; DYNAMIN; GAMMA INTERFERON; HLA DR ANTIGEN; LECTIN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE RECEPTOR; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE;

CELL DIFFERENTIATION; CELL SURVIVAL; CHEMISTRY; COLORECTAL TUMOR; CYTOLOGY; DRUG EFFECT; ENDOCYTOSIS; EXOSOME; GENETICS; HUMAN; IMMUNOPHENOTYPING; MACROPHAGE; METABOLISM; MONOCYTE; PATHOLOGY; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOKINES; COLORECTAL NEOPLASMS; CYTOKINES; DYNAMINS; ENDOCYTOSIS; EXTRACELLULAR VESICLES; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; LECTINS, C-TYPE; LIPOPOLYSACCHARIDE RECEPTORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MANNOSE-BINDING LECTINS; MONOCYTES; RECEPTORS, CELL SURFACE; TETRADECANOYLPHORBOL ACETATE;

EID: 85045932351     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/s12964-018-0229-y     Document Type: Article

References (39)

1. Penfornis P, Vallabhaneni KC, Whitt J, Pochampally R. Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment. Int J Cancer. 2016;138:14-21.
2. Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3
3. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology. 2008;10:1470-U1209.
4. Khalyfa A, Almendros I, Gileles-Hillel A, Akbarpour M, Trzepizur W, Mokhlesi B, Huang L, Andrade J, Farre R, Gozal D. Circulating exosomes potentiate tumor malignant properties in a mouse model of chronic sleep fragmentation. Oncotarget. 2016;7:54676-54,690.
5. Vader P, Breakefield XO, Wood MJ. Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med. 2014;20:385-93.
6. Chowdhury R, Webber JP, Gurney M, Mason MD, Tabi Z, Clayton A. Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts. Oncotarget. 2015;6:715-31.
7. Sanchez CA, Andahur EI, Valenzuela R, Castellon EA, Fulla JA, Ramos CG, Trivino JC. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche. Oncotarget. 2016;7:3993-4008.
8. Berchem G, Noman MZ, Bosseler M, Paggetti J, Baconnais S, Le Cam E, Nanbakhsh A, Moussay E, Mami-Chouaib F, Janji B, Chouaib S. Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF- and miR23a transfer. Oncoimmunology. 2016;5
9. Williams CB, Yeh ES, Soloff AC. Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer. 2016;2
10. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 2006;42:717-27.
11. Baj-Krzyworzeka M, Mytar B, Szatanek R, Surmiak M, Weglarczyk K, Baran J, Siedlar M. Colorectal cancer-derived microvesicles modulate differentiation of human monocytes to macrophages. Journal of Translational Medicine. 2016;14
12. Illemann M, Laerum OD, Hasselby JP, Thurison T, Hoyer-Hansen G, Nielsen HJ, Christensen IJ. Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer. Cancer Medicine. 2014;3:855-64.
13. Li Y, Sun BS, Pei BX, Li CG, Zhang ZF, Yin YS, Wang CL. Osteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival. Annals of Thoracic Surgery. 2015;99:1140-8.
14. Lin CN, Wang CJ, Chao YJ, Lai MD, Shan YS. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression. Bmc Cancer. 2015;15:128.
15. Gwak JM, Jang MH, Kim DI, Seo AN, Park SY. Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer. Plos One. 2015;10(4):e0125728. https://doi.org/10.1371/journal.pone.0125728.
16. Yuan ZY, Luo RZ, Peng RJ, Wang SS, Xue C. High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis. OncoTargets and Therapy. 2014;7:1475-80.
17. Subimerb C, Pinlaor S, Khuntikeo N, Leelayuwat C, Morris A, McGrath MS, Wongkham S. Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma. Molecular Medicine Reports. 2010;3:597-605.
18. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev. Cancer. 2006;6:449-58.
19. Genin M, Clement F, Fattaccioli A, Raes M, Michiels C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. Bmc Cancer. 2015;15
20. Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, Zhou Q, Sui SF. Cellular Internalization of Exosomes Occurs Through Phagocytosis. Traffic. 2010;11:675-87.
21. Escrevente C, Keller S, Altevogt P, Costa J. Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer. 2011;11:108.
22. Kirchhausen T, Macia E, Pelish HE. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Small Gtpases in Disease, Part A. 2008;438:77-93.
23. Barres C, Blanc L, Bette-Bobillo P, Andre S, Mamoun R, Gabius HJ, Vidal M. Galectin-5 is bound onto the surface of rat reticulocyte exosomes and modulates vesicle uptake by macrophages. Blood. 2010;115:696-705.
24. Nishida-Aoki N, Tominaga N, Takeshita F, Sonoda H, Yoshioka Y, Ochiya T. Disruption of Circulating Extracellular Vesicles as a Novel Therapeutic Strategy against Cancer Metastasis. Molecular Therapy. 2017;25:181-91.
25. Dutta D, Donaldson JG. Search for inhibitors of endocytosis: Intended specificity and unintended consequences. Cell Logist. 2012;2:203-8.
26. Yuan A, Hsiao YJ, Chen HY, Chen HW, Ho CC, Chen YY, Liu YC, Hong TH, Yu SL, Chen JJ, Yang PC. Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression. Sci Rep. 2015;5:14273.
27. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122:787-95.
28. Helm O, Held-Feindt J, Schafer H, Sebens S. M1 and M2: there is no "good" and "bad"-How macrophages promote malignancy-associated features in tumorigenesis. Oncoimmunology. 2014;3
29. Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976;36:4562-9.
30. Preta G, Cronin JG, Sheldon IM. Dynasore - not just a dynamin inhibitor. Cell Commun Signal. 2015;13:24.
31. Li C, Luo X, Lin Y, Tang X, Ling L, Wang L, Jiang Y. A Higher Frequency of CD14+ CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer. PLoS One. 2015;10:e0141817.
32. Toiyama Y, Fujikawa H, Kawamura M, Matsushita K, Saigusa S, Tanaka K, Inoue Y, Uchida K, Mohri Y, Kusunoki M. Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer. Int J Oncol. 2012;40:560-6.
33. Zipin-Roitman A, Meshel T, Sagi-Assif O, Shalmon B, Avivi C, Pfeffer RM, Witz IP, Ben-Baruch A. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res. 2007;67:3396-405.
34. Stanilov NS, Dobreva ZG, Stanilova SA. Higher Tnf-Alpha Production Detected in Colorectal Cancer Patients Monocytes. Biotechnology & Biotechnological Equipment. 2012;26:107-10.
35. Chang PH, Pan YP, Fan CW, Tseng WK, Huang JS, Wu TH, Chou WC, Wang CH, Yeh KY. Pretreatment serum interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha levels predict the progression of colorectal cancer. Cancer Med. 2016;5:426-33.
36. Mager LF, Wasmer MH, Rau TT, Krebs P. Cytokine-Induced Modulation of Colorectal Cancer. Front Oncol. 2016;6:96.
37. Miteva LD, Stanilov NS, Deliysky TS, Stanilova SA. Significance of -1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10 expression. Tumor Biology. 2014;35:12655-12,664.
38. Abtahi S, Davani F, Mojtahedi Z, Hosseini SV, Bananzadeh A, Ghaderi A. Dual association of serum interleukin-10 levels with colorectal cancer. J Cancer Res Ther. 2017;13:252-6.
39. Schetter AJ, Nguyen GH, Bowman ED, Mathe EA, Yuen ST, Hawkes JE, Croce CM, Leung SY, Harris CC. Association of Inflammation-Related and microRNA Gene Expression with Cancer-Specific Mortality of Colon Adenocarcinoma. Clinical Cancer Research. 2009;15:5878-87.